News | January 08, 2025
Ajooni Biotech to raise Rs. 45 crore through convertible warrants
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
The biosimilar Ustekinumab has been developed and manufactured by the company
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
ICMR will continue to track trends in HMPV circulation throughout the year
The order, part of an international framework agreement is to be executed between February to April, 2025
The acquired hospital is a well-established hospital based out of Model Town, New Delhi
Subscribe To Our Newsletter & Stay Updated
